Purpose: In competitive sports, optimizing performance is the key. An interesting venue to explore is to consider drafting as a pacing strategy. The purpose of this study is to identify the magnitude of drafting benefits for biomechanical, physiological, and psychobiological parameters in and between athletes in cycling, kayaking, running, skating, skiing, and swimming.
Design: A systematic review and meta-analysis.
Methods: Systematic searches were performed in PubMed, Web of Science, and Embase databases.
Results: In total, 205 studies were found, from which 22 were relevant (including 232 participants and 548 observations). Methodological quality was high for all the included articles. The meta-analyses for all parameters indicated strong evidence for a benefit of drafting, with moderate effects between leading and drafting athletes found for the heart rate (3.9%), VO (8.9%), power output (11.3%), and rating of perceived exertion (10.4%). Large effect sizes were found for blood lactate (24.2%), VE (16.2%), and EMG (56.4%). A moderator analysis showed differences between sports on the effect of drafting with most benefits in cycling. . Based on the observed effects of drafting in the biomechanical, physiological, and psychobiological parameters, it can be considered as an element of pacing, a strategy to conserve energy and optimize performance.
Conclusion: There is strong evidence that drafting benefits athletes, with varying levels of effect for athletes in different sports. Knowledge about the magnitude of benefits can be used to improve training sessions, race strategies, and performance in competition.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11022785 | PMC |
http://dx.doi.org/10.1155/2023/3254847 | DOI Listing |
Introduction: Canadian youth mental health (YMH) systems have the potential to urgently tackle the mental health treatment gap currently impacting young people, and stepped care (SC) is one model that can address this need. The adoption of SC models can guide the development of better-connected YMH systems by simplifying transitions and care pathways. To do so requires robust standards that are co-created across stakeholder groups, including with lived experience experts, to ensure the effective implementation of SC models.
View Article and Find Full Text PDFEast Mediterr Health J
December 2024
Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Background: Waterpipe tobacco smoking is increasing in Egypt, although there are several interventions to reduce its use.
Aim: To describe the development of a policy brief to reform waterpipe tobacco taxation in Egypt.
Methods: During 2019-2022, we synthesized available literature evidence on waterpipe tobacco taxation in Egypt and other countries.
Alzheimers Dement
December 2024
Cognition Therapeutics, Purchase, New York, USA.
The Alzheimer's Disease Neuroimaging Initiative (ADNI) Private Partners Scientific Board (PPSB) Diversity, Equity, and Inclusion Working Group (DE&I WG) was established to work with the ADNI3 Diversity Task Force to provide an industry perspective on increasing the representation of diverse participants in ADNI3 and to build precompetitive cross-industry knowledge in engagement and recruitment of under-represented participants (URPs). In this article, we review and highlight the role and ongoing activities within the ADNI PPSB DE&I WG and provide a cross-industry perspective on areas where precompetitive collaboration can improve the inclusiveness in clinical trials, drawing on examples from ADNI4. HIGHLIGHTS: New collaboration crosses boundaries to allow PPSB DE&I WG members to work together in a preproprietary way.
View Article and Find Full Text PDFSports Med
December 2024
Australian Catholic University, North Sydney, NSW, Australia.
Paediatr Drugs
December 2024
Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
New drugs for Duchenne muscular dystrophy (DMD) are emerging rapidly. However, we and others believe these drugs are achieving regulatory approval prematurely. It is the cardiorespiratory complications of DMD that cause the disease's major morbidities and that determine survival.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!